Skip to main content
SpringerLink
Log in

I Am Tired of Taking Pills for My Reflux, What Else Can I Do? Surgical and Endoscopic Treatment for GERD

  • Chapter
  • First Online:
Gastrointestinal Motility Disorders

Abstract

Gastroesophageal reflux disease is an extremely common gastrointestinal condition. While first-line treatment is lifestyle modifications and medical therapy, this approach fails to completely control symptoms in many patients. In patients with persistent symptoms of GERD despite acid suppression, safe and effective surgical and endoscopic interventions are readily available and can lead to durable symptom control and minimal side effects when properly performed in appropriate patients. Unfortunately, antireflux surgical and endoscopic interventions are underutilized with an estimated 1% or less of candidates undergoing one of these procedures despite clear potential for benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pope CE. Acid-reflux disorders. N Engl J Med. 1994;331(10):656–60.

    Article  PubMed  Google Scholar 

  3. Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Ther Adv Gastroenterol. 2012;5(4):219–32.

    Article  Google Scholar 

  4. Metz DC. Managing gastroesophageal reflux disease for the lifetime of the patient: evaluating the long-term options. Am J Med. 2004;117(Suppl 5A):49S–55S.

    PubMed  Google Scholar 

  5. Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, Doblhammer G, Haenisch B. Association of proton pump inhibitors with risk of dementia: pharmacoepidemiological claims data analysis. JAMA Neurol. 2016;73(4):410–6.

    Article  PubMed  Google Scholar 

  6. Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2016;27(10):3153–63. pii: ASN.2015121377

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fass R. Therapeutic options for refractory gastroesophageal reflux disease. J Gastroenterol Hepatol. 2012;27(suppl 3):3–7.

    Article  CAS  PubMed  Google Scholar 

  8. Fass R, Hershcovici T. Step by step management of refractory gastroesophageal reflux disease. Dis Esophagus. 2012;26(1):27–36.

    PubMed  Google Scholar 

  9. Kahrilas PJ. Gastroesophageal reflux disease. N Engl J Med. 2008;359:1700–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. GERD patient study: patients and their medications. AGA Institute; 2008.

    Google Scholar 

  11. Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg Endosc. 2006;20:1698–701.

    Article  PubMed  Google Scholar 

  12. Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C. Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc. 2006;20(1):159–65.

    Article  CAS  PubMed  Google Scholar 

  13. Engström C, Cai W, Irvine T, Devitt PG, Thompson SK, Game PA, Bessell JR, Jamieson GG, Watson DI. Twenty years of experience with laparoscopic antireflux surgery. Br J Surg. 2012;99(10):1415–21.

    Article  PubMed  Google Scholar 

  14. Rohof WO, Bisschops R, Tack J, Boeckxstaens GE. Postoperative problems: fundoplication and obesity surgery. Gastroenterol Clin N Am. 2011;40:809–21.

    Article  CAS  Google Scholar 

  15. Wang YR, Dempsey DT, Richter JE. Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1992-2006. Dis Esoph. 2011;24:215–23.

    Article  CAS  Google Scholar 

  16. Iqbal A, Awad Z, Simkins J, Shah R, Haider M, Salinas V, Turaga K, Karu A, Mittal SK, Filipi CJ. Repair of 104 failed anti-reflux operations. Ann Surg. 2006;244:42–51.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vikal N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med. 2003;114:1–5.

    Article  Google Scholar 

  18. Richter JE, Dempsey DT. Laparoscopic antireflux surgery: key to success in the community setting. Am J Gastroenterol. 2008;103:289–91.

    Article  PubMed  Google Scholar 

  19. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, SAGES Guidelines Committee. Guidelines for surgical treatment of Gastroesophageal reflux disease (GERD). Surg Endosc. 2010;24(11):2647–69.

    Article  PubMed  Google Scholar 

  20. Lipham JC, Taiganides PA, Louie BE, Ganz RA, DeMeester TR. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2015;28(4):305–11.

    Article  CAS  PubMed  Google Scholar 

  21. Bonavina L, Saino G, Bona D, Sironi A, Lazzari V. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013;217(4):577–85.

    Article  PubMed  Google Scholar 

  22. Ganz RA, Edmundowicz SA, Taiganides PA, Lipham JC, Smith CD, DeVault KR, Horgan S, Jacobsen G, Luketich JD, Smith CC, Schlack-Haerer SC, Kothari SN, Dunst CM, Watson TJ, Peters J, Oelschlager BK, Perry KA, Melvin S, Bemelman WA, Smout AJ, Dunn D. Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux. Clin Gastroenterol Hepatol. 2016;14(5):671–7. S1542-3565(15)00763-6

    Article  PubMed  Google Scholar 

  23. Saino G, Bonavina L, Lipham JC, Dunn D, Ganz RA. Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement. J Laparoendosc Adv Surg Tech A. 2015;25(10):787–92.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ganz RA, Peters JH, Horgan S, Bemelman WA, Dunst CM, Edmundowicz SA, Lipham JC, Luketich JD, Melvin WS, Oeschlager BK, Schlack-Haerer SC, Smith CD, Smith CC, Dunn D, Taiganides PA. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(8):719–27.

    Article  CAS  PubMed  Google Scholar 

  25. Reynolds JL, Zehetner J, Bildzukewicz N, Katkhouda N, Dandekar G, Lipham JC. Magnetic sphincter augmentation with the LINX device for gastroesophageal reflux disease after U.S. Food and Drug Administration approval. Am Surg. 2014;80(10):1034–8.

    PubMed  Google Scholar 

  26. Bauer M, Meining A, Kranzfelder M, Jell A, Schirren R, Wilhelm D, Friess H, Feussner H. Endoluminal perforation of a magnetic antireflux device. Surg Endosc. 2015;29(12):3806–10.

    Article  PubMed  Google Scholar 

  27. Louie BE, Farivar AS, Shultz D, Brennan C, Vallières E, Aye RW. Short-term outcomes using magnetic sphincter augmentation versus Nissen fundoplication for medically resistant gastroesophageal reflux disease. Ann Thorac Surg. 2014;98(2):498–504.

    Article  PubMed  Google Scholar 

  28. Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2015;29(5):1123–9.

    Article  PubMed  Google Scholar 

  29. Reynolds JL, Zehetner J, Wu P, Shah S, Bildzukewicz N, Lipham JC. Laparoscopic magnetic sphincter augmentation vs. laparoscopic Nissen fundoplication: a matched-pair analysis of 100 patients. J Am Coll Surg. 2015;221(1):123–8.

    Article  PubMed  Google Scholar 

  30. Warren HF, Reynolds JL, Lipham JC, Zehetner J, Bildzukewicz NA, Taiganides PA, Mickley J, Aye RW, Farivar AS, Louie BE. Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc. 2016;30(8):3289–96.

    Article  PubMed  Google Scholar 

  31. http://www.sages.org/publications/guidelines/tavac-safety-and-effectiveness-analysis-linx-reflux-management-system/. Accessed 6 Aug 2016.

    Google Scholar 

  32. Ganz RA. A review of new surgical and endoscopic therapies for Gastroesophageal reflux disease. Gastroenterol Hepatol (N Y). 2016;12(7):424–31.

    Google Scholar 

  33. Corley DA, Katz P, Wo JM, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125(3):668–76.

    Article  PubMed  Google Scholar 

  34. Coron E, Sebille V, Cadiot G, et al. Clinical trial: radiofrequency energy delivery in proton pump inhibitor-dependent gastroesophageal reflux disease patients. Aliment Pharmacol Ther. 2008;28(9):1147–58.

    Article  CAS  PubMed  Google Scholar 

  35. Aziz AM, El-Khayat HR, Sadek A, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(4):818–25.

    Article  PubMed  Google Scholar 

  36. Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastroesophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30.

    Article  CAS  PubMed  Google Scholar 

  37. Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28(8):2323–33.

    Article  PubMed  Google Scholar 

  38. Liang WT, Wu JN, Wang F, Hu ZW, Wang ZG, Ji T, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease. Minerva Chir. 2014;69(4):217–23.

    CAS  PubMed  Google Scholar 

  39. Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and metaanalysis. Clin Gastroenterol Hepatol. 2015;13(6):1058–67.

    Article  PubMed  Google Scholar 

  40. Patti M. An evidence based approach to the treatment of gastroesophageal reflux disease. JAMA Surg. 2016;151(1):73–8.

    Article  PubMed  Google Scholar 

  41. Hunter JG, Kahrilas PJ, Bell RC, et al. Efficacy of transoral fundoplication vs. omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33.

    Article  CAS  PubMed  Google Scholar 

  42. Witteman BP, Conchillo JM, Rinsma NF, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–42.

    Article  CAS  PubMed  Google Scholar 

  43. Håkansson B, Montgomery M, Cadiere GB, et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42(11–12):1261–70.

    Article  PubMed  Google Scholar 

  44. Trad KS, Simoni G, Barnes WE, Shughoury AB, Raza M, Heise JA, et al. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol. 2014;14:174.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22(1):26–40.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Wendling MR, Melvin WS, Perry KA. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature. Surg Endosc. 2013;27:3754–61.

    Article  PubMed  Google Scholar 

  47. SAGES Clinical Spotlight Review. Endoscopic treatments for gastroesophageal reflux disease. http://www.sages.org/publications/guidelines/endoluminal-treatments-for-gastroesophageal-reflux-disease-gerd/. Accessed 8 Aug 2016.

    Google Scholar 

  48. ASGE Standards of Practice Committee. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81(6):1305–10.

    Article  Google Scholar 

  49. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28.

    Article  PubMed  Google Scholar 

  50. American Gastroenterological Association Institute. Technology coverage statement on minimally invasive surgical options for gastroesophageal reflux. 2016. https://www.gastro.org/about/Technology_Coverage_Minimally_Invasive_GERD_Procedures.pdf. Accessed 30 Aug 2016.

    Google Scholar 

  51. Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002;97(3):575–83.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA

    Jon Gould M.D.

Authors
  1. Jon Gould M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jon Gould M.D. .

Editor information

Editors and Affiliations

  1. Institute of Gastroenterology, Sheba medical Center, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel

    Eytan Bardan

  2. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Reza Shaker

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Gould, J. (2018). I Am Tired of Taking Pills for My Reflux, What Else Can I Do? Surgical and Endoscopic Treatment for GERD. In: Bardan, E., Shaker, R. (eds) Gastrointestinal Motility Disorders . Springer, Cham. https://doi.org/10.1007/978-3-319-59352-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59352-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59350-0

  • Online ISBN: 978-3-319-59352-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation